glp-1 stdei drugs carry wide variety of risks, benefits beyond weight loss GLP-1 and Gut Health: Addressing

Gallstones: Significant, rapid weight loss is a known trigger for gallbladder issues

Back rskov, C, Holst JJ (April 1987) 'Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)', Scandinavian Journal of Clinical and Laboratory Investigation , 47/2, 165-74.Back rskov, C, Holst, JJ, Seier Poulsen, S, Kirkegaard, P (Nov 1987) 'Pancreatic and intestinal processing of proglucagon in man', Diabetologia, 30, 874-81

Leggio L, Addolorato G, Cippitelli A, Jerlhag E, Kampov-Polevoy AB, Swift RM

YpsoDose is currently being industrialized for use in clinical trials

Today, GLP-1s are the most talked-about weight loss drugs in decades

Correcting identified deficiencies If blood work reveals specific deficiencies (low ferritin, low vitamin D, low zinc, or low B12), targeted correction may be the single most effective intervention